Pancreatic Cancer Research

ResearcherUniversity of PisaNo recent work listed

Romano Danesi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-4414-8934; OpenAlex author ID A5083693387. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers

Papers 7

  1. Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società I… Co-author DOI 10.1016/j.esmoop.2021.100155↗
  2. Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-p… Co-author DOI 10.1038/s41397-020-00203-7↗
  3. Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. Last author DOI 10.3390/cancers13153738↗
  4. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer. Last author DOI 10.2217/pgs-2018-0149↗
  5. Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer. Last author DOI 10.1038/s41598-017-08297-z↗
  6. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Co-author DOI 10.1158/1535-7163.mct-12-0037↗
  7. Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1. Last author DOI 10.1593/neo.12772↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eleonora Rofi · 4 shared papers, 2017–2021 · strength 0.38
  2. Marzia Del Re · 4 shared papers, 2017–2021 · strength 0.38
  3. Caterina Vivaldi · 4 shared papers, 2017–2021 · strength 0.38
  4. Lorenzo Fornaro · 4 shared papers, 2017–2021 · strength 0.38
  5. Enrico Vasile · 4 shared papers, 2017–2021 · strength 0.38
  6. Silvia Catanese · 2 shared papers, 2021 · strength 0.23
  7. Niccola Funel · 2 shared papers, 2012–2019 · strength 0.12
  8. Irene Pecora · 1 shared paper, 2021 · strength 0.11
  9. Marco Gallo · 1 shared paper, 2021 · strength 0.10
  10. Antonella Argentiero · 1 shared paper, 2021 · strength 0.10
  11. Pietro Ferrari · 1 shared paper, 2021 · strength 0.10
  12. Antonio Dello Russo · 1 shared paper, 2021 · strength 0.10
  13. Nicola Silvestris · 1 shared paper, 2021 · strength 0.10
  14. Francesco Giorgino · 1 shared paper, 2021 · strength 0.10
  15. Chiara Caparello · 1 shared paper, 2017 · strength 0.07
  16. Amir Avan · 1 shared paper, 2012 · strength 0.03
  17. Guido Bocci · 1 shared paper, 2012 · strength 0.03
  18. Godefridus J. Peters · 1 shared paper, 2012 · strength 0.03
  19. Elisa Giovannetti · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.